A randomised placebo-controlled trial of combined mitochondrial agents for the treatment of fatigue and depression in multiple sclerosis with an assessment of the impact on kynurenine pathway metabolomics
Researchers
-
Anne-Louise Ponsonby
(Primary Investigator)
-
Simon Broadley
(Secondary Investigator)
-
John Christodoulou
(Secondary Investigator)
-
Brisa Fernandes
(Secondary Investigator)
-
Felice N Jacka
(Secondary Investigator)
-
J Lechner-Scott
(Secondary Investigator)
-
Emeritus Professor Robyn Lucas
(Secondary Investigator)
-
Professor Anne-Louise Ponsonby
(Secondary Investigator)
-
B V Taylor
(Secondary Investigator)
-
Ingrid Van Der Mei
(Secondary Investigator)
-
Damjan Vukcevic
(Secondary Investigator)
Grant status
Completed
Grant start date
30/06/2018
Grant funding
-
2018: $192,542 from Medical Research Future Fund (MRFF)
-
2019: $395,544 from Medical Research Future Fund (MRFF)
-
2020: $298,986 from Medical Research Future Fund (MRFF)